Targeting kinesin family member 21B by miR-132-3p represses cell proliferation, migration and invasion in gastric cancer

References

• Bozkurt O, Firat ST, Dogan E, et al. The prognostic value of the change in neutrophil-to-lymphocyte ratio during first-line palliative chemotherapy in patients with metastatic gastric cancer: a retrospective study. J Buon. 2019;24:1992–1999.
   PubMed Web of Science ®Google Scholar
• Sitarz R, Skierucha M, Mielko J, et al. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018;10:239–248.
   PubMed Web of Science ®Google Scholar
• Baba H, Kuwabara K, Ishiguro T, et al. Prognostic factors for stage IV gastric cancer. Int Surg. 2013;98:181–187.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Lan X, Li N, et al. Analysis of prognostic factors and design of prognosis model for patients with stage IV gastric cancer following first-line palliative chemotherapy. Cancer Manag Res. 2020;12:10461–10468.
   PubMed Web of Science ®Google Scholar
• Hirokawa N, Tanaka Y. Kinesin superfamily proteins (KIFs): various functions and their relevance for important phenomena in life and diseases. Exp Cell Res. 2015;334:16–25.
   PubMed Web of Science ®Google Scholar
• Hirokawa N, Noda Y. Intracellular transport and kinesin superfamily proteins, KIFs: structure, function, and dynamics. Physiol Rev. 2008;88:1089–1118.
   PubMed Web of Science ®Google Scholar
• Hirokawa N, Noda Y, Tanaka Y, et al. Kinesin superfamily motor proteins and intracellular transport. Nat Rev Mol Cell Biol. 2009;10:682–696.
   PubMed Web of Science ®Google Scholar
• Myers SM, Collins I. Recent findings and future directions for interpolar mitotic kinesin inhibitors in cancer therapy. Future Med Chem. 2016;8:463–489.
   PubMed Web of Science ®Google Scholar
• Liu X, Gong H, Huang K. Oncogenic role of kinesin proteins and targeting kinesin therapy. Cancer Sci. 2013;104:651–656.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhan P, Zhou Z, et al. The overexpression of KIFC1 was associated with the proliferation and prognosis of non-small cell lung cancer. J Thorac Dis. 2016;8:2911–2923.
   PubMed Web of Science ®Google Scholar
• Muhia M, Thies E, Labonte D, et al. The Kinesin KIF21B regulates microtubule dynamics and is essential for neuronal morphology, synapse function, and learning and memory. Cell Rep. 2016;15:968–977.
   PubMed Web of Science ®Google Scholar
• Kreft KL, van Meurs M, Wierenga-Wolf AF, et al. Abundant kif21b is associated with accelerated progression in neurodegenerative diseases. Acta Neuropathol Commun. 2014;2:144.
   PubMed Web of Science ®Google Scholar
• Hares K, Miners JS, Cook AJ, et al. Overexpression of Kinesin superfamily motor proteins in Alzheimer’s Disease. J Alzheimers dis. 2017;60:1511–1524.
   PubMed Web of Science ®Google Scholar
• Zhao HQ, Dong BL, Zhang M, et al. Increased KIF21B expression is a potential prognostic biomarker in hepatocellular carcinoma. World J Gastrointest Oncol. 2020;12:276–288.
   PubMed Web of Science ®Google Scholar
• Sun ZG, Pan F, Shao JB, et al. Kinesin superfamily protein 21B acts as an oncogene in non-small cell lung cancer. Cancer Cell Int. 2020;20:233.
   PubMed Web of Science ®Google Scholar
• Kunej T, Godnic I, Ferdin J, et al. Epigenetic regulation of microRNAs in cancer: an integrated review of literature. Mutat Res. 2011;717:77–84.
   PubMed Web of Science ®Google Scholar
• Cortez MA, Anfossi S, Ramapriyan R, et al. Role of miRNAs in immune responses and immunotherapy in cancer. Genes Chromosomes Cancer. 2019;58:244–253.
   PubMed Web of Science ®Google Scholar
• Jia XN, Yin SD, Wei Y, et al. MiR-182-5p inhibited proliferation and migration of ovarian cancer cells by targeting BNIP3. Eur Rev Med Pharmacol Sci. 2020;24:7912.
   PubMed Web of Science ®Google Scholar
• Wang L, Wang Y, Du X, et al. MiR-216b suppresses cell proliferation, migration, invasion, and epithelial-mesenchymal transition by regulating FOXM1 expression in human non-small cell lung cancer. Onco Targets Ther. 2019;12:2999–3009.
   PubMed Web of Science ®Google Scholar
• Li S, Xu JJ, Zhang QY. MicroRNA-132-3p inhibits tumor malignant progression by regulating lysosomal-associated protein transmembrane 4 beta in breast cancer. Cancer Sci. 2019;110:3098–3109.
   PubMed Web of Science ®Google Scholar
• Wu B, Li J, Wang H, et al. MiR-132-3p serves as a tumor suppressor in mantle cell lymphoma via directly targeting SOX11. Naunyn-Schmiedeberg’s Arch Pharmacol. 2020;393:2197–2208.
   Google Scholar
• He X, Ma J, Zhang M, et al. Long non-coding RNA SNHG16 activates USP22 expression to promote colorectal cancer progression by sponging miR-132-3p. Onco Targets Ther. 2020;13:4283–4294.
   PubMed Web of Science ®Google Scholar
• Zhang M, Li Y, Wang H, et al. LncRNA SNHG5 affects cell proliferation, metastasis and migration of colorectal cancer through regulating miR-132-3p/CREB5. Cancer Biol Ther. 2019;20:524–536.
   PubMed Web of Science ®Google Scholar
• Guan H, Shang G, Cui Y, et al. Long noncoding RNA APTR contributes to osteosarcoma progression through repression of miR-132-3p and upregulation of yes-associated protein 1. J Cell Physiol. 2019;234:8998–9007.
   PubMed Web of Science ®Google Scholar
• Li G, Liu K, Du X. Long non-coding RNA TUG1 promotes proliferation and inhibits apoptosis of osteosarcoma cells by sponging miR-132-3p and upregulating SOX4 expression. Yonsei Med J. 2018;59:226–235.
   PubMed Web of Science ®Google Scholar
• Liu P, Li X, Guo X, et al. Circular RNA DOCK1 promotes bladder carcinoma progression via modulating circDOCK1/hsa-miR-132-3p/Sox5 signalling pathway. Cell Prolif. 2019;52:e12614.
   PubMed Web of Science ®Google Scholar
• Zhang T, Liu C, Huang S, et al. A downmodulated MicroRNA profiling in patients with gastric cancer. Gastroenterol Res Pract. 2017;2017:1526981.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang H, Zhou X, et al. Five serum-based miRNAs were identified as potential diagnostic biomarkers in gastric cardia adenocarcinoma. Cancer Biomarkers. 2018;23:193–203.
   PubMed Web of Science ®Google Scholar
• Wang Q, Wen YG, Li DP, et al. Upregulated INHBA expression is associated with poor survival in gastric cancer. Med Oncol. 2012;29:77–83.
   PubMed Web of Science ®Google Scholar
• Chen X, Leung SY, Yuen ST, et al. Variation in gene expression patterns in human gastric cancers. Mol Biol Cell. 2003;14:3208–3215.
   PubMed Web of Science ®Google Scholar
• D’Errico M, de Rinaldis E, Blasi MF, et al. Genome-wide expression profile of sporadic gastric cancers with microsatellite instability. Eur J Cancer. 2009;45:461–469.
   PubMed Web of Science ®Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19:649–658.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR. Methods. 2002;25:402–408.
   Web of Science ®Google Scholar
• Huszar D, Theoclitou ME, Skolnik J, et al. Kinesin motor proteins as targets for cancer therapy. Cancer Metastasis Rev. 2009;28:197–208.
   PubMed Web of Science ®Google Scholar
• Lucanus AJ, Yip GW. Kinesin superfamily: roles in breast cancer, patient prognosis and therapeutics. Oncogene. 2018;37:833–838.
   PubMed Web of Science ®Google Scholar
• Yang Z, Li C, Yan C, et al. KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer. Biochimica et biophysica acta Mol basis dis. 2019;1865:181–192.
   PubMed Web of Science ®Google Scholar
• Wang ZZ, Yang J, Jiang BH, et al. KIF14 promotes cell proliferation via activation of Akt and is directly targeted by miR-200c in colorectal cancer. Int J Oncol. 2018;53:1939–1952.
   PubMed Web of Science ®Google Scholar
• Zhou J, Chen WR, Yang LC, et al. KIF11 functions as an oncogene and is associated with poor outcomes from breast cancer. Cancer Res Treat. 2019;51:1207–1221.
   PubMed Web of Science ®Google Scholar
• Li XL, Ji YM, Song R, et al. KIF23 promotes gastric cancer by stimulating cell proliferation. Dis Markers. 2019;2019:9751923.
   PubMed Web of Science ®Google Scholar
• Ni S, Li J, Qiu S, et al. KIF21B expression in osteosarcoma and its regulatory effect on osteosarcoma cell proliferation and apoptosis through the PI3K/AKT pathway. Front Oncol. 2020;10:606765.
   PubMed Web of Science ®Google Scholar
• Yang Y, Gao L, Weng NN, et al. Identification of novel molecular therapeutic targets and their potential prognostic biomarkers among kinesin superfamily of proteins in pancreatic ductal adenocarcinoma. Front Oncol. 2021;11:708900.
   PubMed Web of Science ®Google Scholar
• Kara M, Yumrutas O, Ozcan O, et al. Differential expressions of cancer-associated genes and their regulatory miRNAs in colorectal carcinoma. Gene. 2015;567:81–86.
   PubMed Web of Science ®Google Scholar
• Zhang H, Liu A, Feng X, et al. MiR-132 promotes the proliferation, invasion and migration of human pancreatic carcinoma by inhibition of the tumor suppressor gene PTEN. Prog Biophys Mol Biol. 2019;148:65–72.
   PubMed Web of Science ®Google Scholar
• Zhou K, Zhang C, Yao H, et al. Knockdown of long non-coding RNA NEAT1 inhibits glioma cell migration and invasion via modulation of SOX2 targeted by miR-132. Mol Cancer. 2018;17:105.
   PubMed Web of Science ®Google Scholar
• He L, Qu L, Wei L, et al. Reduction of miR‑132‑3p contributes to gastric cancer proliferation by targeting MUC13. Mol Med Rep. 2017;15:3055–3061.
   PubMed Web of Science ®Google Scholar
• Li G, Chong T, Yang J, et al. Kinesin motor protein KIFC1 is a target protein of miR-338-3p and is associated with poor prognosis and progression of renal cell carcinoma. Oncol Res. 2018;27:125–137.
   PubMed Web of Science ®Google Scholar
• Wang B, Yu J, Sun Z, et al. Kinesin family member 11 is a potential therapeutic target and is suppressed by microRNA-30a in breast cancer. Mol Carcinog. 2020;59:908–922.
   PubMed Web of Science ®Google Scholar
• Sheng N, Xu YZ, Xi QH, et al. Overexpression of KIF2A is suppressed by miR-206 and associated with poor prognosis in ovarian cancer. Cell Physiol Biochem. 2018;50:810–822.
   PubMedGoogle Scholar
• Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004;20:781–810.
   PubMed Web of Science ®Google Scholar
• Talbot LJ, Bhattacharya SD, Kuo PC. Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies. Int J Biochem Mol Biol. 2012;3:117–136.
   PubMedGoogle Scholar
• Guo H, Zhang X, Chen Q, et al. miR-132 suppresses the migration and invasion of lung cancer cells by blocking USP9X-induced epithelial-mesenchymal transition. Am J Transl Res. 2018;10:224–234.
   PubMed Web of Science ®Google Scholar
• You J, Li Y, Fang N, et al. MiR-132 suppresses the migration and invasion of lung cancer cells via targeting the EMT regulator ZEB2. PloS one. 2014;9:e91827.
   PubMed Web of Science ®Google Scholar
• Zhao JL, Zhang L, Guo X, et al. miR-212/132 downregulates SMAD2 expression to suppress the G1/S phase transition of the cell cycle and the epithelial to mesenchymal transition in cervical cancer cells. IUBMB Life. 2015;67:380–394.
   PubMed Web of Science ®Google Scholar
• Gu S, Liang H, Qi D, et al. Knockdown of KIF26B inhibits breast cancer cell proliferation, migration, and invasion. Onco Targets Ther. 2018;11:3195–3203.
   PubMed Web of Science ®Google Scholar
• Liu Y, Chen H, Dong P, et al. KIF23 activated Wnt/β-catenin signaling pathway through direct interaction with Amer1 in gastric cancer. Aging (Albany NY). 2020;12:8372–8396.
   PubMedGoogle Scholar